title: Sentinel lymphonodectomy in gastrointestinal cancer--where are we now?
abstract: Up to now, no reliable methods for the pre- or intraoperative prediction of the nodal status are available in gastrointestinal cancer patients. Therefore, after the successful application of the sentinel lymph node concept in melanoma and breast cancer, ongoing research on this field is extended to gastrointestinal tumor entities. According to recent experiences, the most promising tumor entities are colon, gastric and anal cancer. First results with these patients indicate that the method could be a reliable predictor of the nodal status and, thus, may have important future implications for adjuvant therapy and the extent of surgery. The dye method for colon cancer and the combined method (dye and radiocolloid) for gastric cancer seem to be appropriate approaches, even when the general experience is still low. In rectal cancer, however, current experience failed yet to yield satisfying results. Up to now, anal cancer has not been a focus of publication, even when the concept seems to be very attractive for the evaluation of the inguinal lymph node status.
authors.affiliation: Robert-Rössle-Klinik im Helios Klinikum Berlin, Universitätsklinikum Charité, Berlin, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Bembenek
authors.forename: S
authors.initials: S
authors.lastname: Bayraktar
authors.forename: S
authors.initials: S
authors.lastname: Gretschel
authors.forename: C
authors.initials: C
authors.lastname: Ulmer
authors.forename: T
authors.initials: T
authors.lastname: Schulze
authors.forename: J
authors.initials: J
authors.lastname: Markwardt
authors.forename: U
authors.initials: U
authors.lastname: Schneider
authors.forename: M
authors.initials: M
authors.lastname: Hünerbein
authors.forename: P M
authors.initials: PM
authors.lastname: Schlag
mesh_terms: D005770:Gastrointestinal Neoplasms / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis; D011379:Prognosis; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*